CollPlant Biotechnologies Ltd.
CLGN
$3.41
-$0.17-4.75%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 60.00K | 179.00K | 2.06M | 164.00K | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 60.00K | 179.00K | 2.06M | 164.00K | |
| Cost of Revenue | 192.00K | 186.00K | 188.00K | 272.00K | |
| Gross Profit | -132.00K | -7.00K | 1.87M | -108.00K | |
| SG&A Expenses | 1.04M | 1.16M | 1.41M | 1.32M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 3.21M | 3.36M | 3.70M | 4.14M | |
| Operating Income | -3.15M | -3.18M | -1.65M | -3.97M | |
| Income Before Tax | -3.21M | -3.35M | -1.45M | -3.88M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -3.21M | -3.35M | -1.45M | -3.88M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -3.21M | -3.35M | -1.45M | -3.88M | |
| EBIT | -3.15M | -3.18M | -1.65M | -3.97M | |
| EBITDA | -2.93M | -2.95M | -1.40M | -3.73M | |
| EPS Basic | -2.51 | -2.83 | -1.27 | -3.39 | |
| Normalized Basic EPS | -1.57 | -1.77 | -- | -2.12 | |
| EPS Diluted | -2.51 | -2.83 | -1.27 | -3.39 | |
| Normalized Diluted EPS | -1.57 | -1.77 | -- | -2.12 | |
| Average Basic Shares Outstanding | 1.28M | 1.18M | 1.15M | 1.15M | |
| Average Diluted Shares Outstanding | 1.28M | 1.18M | 1.15M | 1.15M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |